Huakang Biomedical Holdings Company Limited (8622.HK)
8622.HK Stock Price Chart
Explore Huakang Biomedical Holdings Company Limited interactive price chart. Choose custom timeframes to analyze 8622.HK price movements and trends.
8622.HK Company Profile
Discover essential business fundamentals and corporate details for Huakang Biomedical Holdings Company Limited (8622.HK) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
13 Dec 2018
Employees
91.00
CEO
Chunguang Zhang
Description
Huakang Biomedical Holdings Company Limited, an investment holding company, engages in the research, development, manufacture, marketing, and sale of in-vitro diagnostic (IVD) reagents in the People's Republic of China. It offers male and female fertility IVD, parasite antibody detection, and Epstein-Barr virus antibody detection reagents; auxiliary reproductive supplies and equipment; and healthcare products and supplements under the Nutronic brand to customers, as well as through online and offline platforms and channels. The company sells its products directly to hospitals and medical institutions, as well as to distributors. Huakang Biomedical Holdings Company Limited was founded in 1992 and is headquartered in Wan Chai, Hong Kong.
8622.HK Financial Timeline
Browse a chronological timeline of Huakang Biomedical Holdings Company Limited corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 28 Mar 2025
EPS came in at -$0.00 , while revenue for the quarter reached $7.15M .
Earnings released on 15 Nov 2024
EPS came in at -$0.00 , while revenue for the quarter reached $7.44M .
Earnings released on 16 Aug 2024
EPS came in at -$0.00 , while revenue for the quarter reached $6.40M .
Earnings released on 14 Jun 2024
EPS came in at -$0.00 , while revenue for the quarter reached $6.45M .
Earnings released on 29 Mar 2024
EPS came in at -$0.01 , while revenue for the quarter reached $7.59M .
Earnings released on 14 Nov 2023
EPS came in at -$0.00 , while revenue for the quarter reached $6.77M .
Earnings released on 10 Aug 2023
EPS came in at -$0.00 , while revenue for the quarter reached $6.17M .
Earnings released on 13 May 2023
EPS came in at -$0.00 , while revenue for the quarter reached $6.58M .
Earnings released on 25 Mar 2023
EPS came in at -$0.01 , while revenue for the quarter reached $7.49M .
Earnings released on 9 Nov 2022
EPS came in at -$0.00 , while revenue for the quarter reached $6.90M .
Earnings released on 30 Sept 2022
EPS came in at $0.00 , while revenue for the quarter reached $7.64M .
Earnings released on 31 Mar 2022
EPS came in at -$0.00 , while revenue for the quarter reached $7.27M .
Earnings released on 31 Dec 2021
EPS came in at -$0.01 , while revenue for the quarter reached $9.25M .
Earnings released on 30 Sept 2021
EPS came in at -$0.00 , while revenue for the quarter reached $7.72M .
Earnings released on 30 Jun 2021
EPS came in at -$0.00 , while revenue for the quarter reached $8.75M .
Earnings released on 31 Mar 2021
EPS came in at -$0.00 , while revenue for the quarter reached $5.79M .
Earnings released on 31 Dec 2020
EPS came in at -$0.01 , while revenue for the quarter reached $9.34M .
Earnings released on 30 Sept 2020
EPS came in at -$0.00 , while revenue for the quarter reached $7.86M .
8622.HK Stock Performance
Access detailed 8622.HK performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.